DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

LALPATHLAB vs VIJAYA: Stock Comparison

DR. LAL PATH LABS vs VIJAYA DIAGNOSTIC CENUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

DR. LAL PATH LABS is the larger company by market capitalisation. DR. LAL PATH LABS shows a lower P/E, a higher ROE and a higher dividend yield, while VIJAYA DIAGNOSTIC CEN shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

LALPATHLAB leads 7; VIJAYA leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

LALPATHLABVIJAYA

Valuation lens

What price are you paying?

Market CapContext only
₹33,301 Cr
₹14,449 Cr
P/E RatioLALPATHLAB has the lower reading
57.01x ✓
70.88x
P/B RatioLALPATHLAB has the lower reading
12.11x ✓
13.65x
EPSLALPATHLAB has the higher reading
₹11.45 ✓
₹5.77
Book ValueContext only
₹151.4
₹92.93
Dividend YieldLALPATHLAB has the higher reading
0.63% ✓
0.14%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LALPATHLAB is the larger company
₹33,301 Cr vs ₹14,449 Cr
P/E Ratio
LALPATHLAB has a lower P/E
57.01x vs 70.88x
P/B Ratio
LALPATHLAB has a lower P/B
12.11x vs 13.65x
EPS
LALPATHLAB has higher earnings per share
₹11.45 vs ₹5.77
Dividend Yield
LALPATHLAB has a higher dividend yield
0.63% vs 0.14%
Revenue Growth (TTM YoY)
VIJAYA has faster revenue growth
26.6% vs 16.6%
EPS Growth (TTM YoY)
VIJAYA has faster EPS growth
38% vs -15.4%
Qtr Sales Growth
VIJAYA has stronger quarterly sales growth
10.57% vs 9.55%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLALPATHLABVIJAYA
SectorHealthcareHealthcare
IndustryHealthcare Service ProviderHealthcare Service Provider

Price

MetricLALPATHLABVIJAYA
Live Price₹1,993₹1,410.1
Day Change-0.79%-0.39%
Volume1.45 L55,287
52-Week High₹3,309.2₹1,593.6
52-Week Low₹1,272.6₹848
Distance from 52W High-39.77%-11.51%

Valuation

MetricLALPATHLABVIJAYA
Market Cap₹33,301 Cr₹14,449 Cr
P/E Ratio57.01x70.88x
P/B Ratio12.11x13.65x
EPS₹11.45₹5.77
Book Value₹151.4₹92.93
Dividend Yield0.63%0.14%

Growth

MetricLALPATHLABVIJAYA
Revenue Growth (TTM YoY)16.6%26.6%
EPS Growth (TTM YoY)-15.4%38%
Qtr Sales Growth9.55%10.57%
Qtr Profit Growth13.72%12%

Profitability & Leverage

MetricLALPATHLABVIJAYA
ROE20.06%18.86%
ROCE24.86%22.72%
Net Margin18.27%20.91%
Operating Margin25.04%34.93%
Debt to Equity0x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricLALPATHLABVIJAYA
Promoter Holding51.09%▼ 0.26 pp52.46%▼ 0.01 pp
FII Holding18.73%▲ 1.37 pp10.66%▼ 0.99 pp
DII Holding21.58%▼ 0.01 pp32.5%▲ 0.92 pp
Public Holding6.35%▼ 1.12 pp4.38%▲ 0.07 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. LAL PATH LABS and VIJAYA DIAGNOSTIC CEN.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.